You are here:
Information Letter regarding Relistor®: Occurrence of gastrointestinal perforations
2010.09.13
Active substance: methylnaltrexone bromide
Important safety information on the occurrence of gastrointestinal perforations in patients who received RELISTOR® (active substance: methylnaltrexone bromide) for subcutaneous injection.
An Rote-Hand-Brief including the
will be circulated.
Download DHPC / Information letter , Download_VeroeffentlichtAm_EN